Ciprofloxacin resistance in Campylobacter jejuni: Case-case analysis as a tool for elucidating risks at home and abroad

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 4, 2002, Pages 561-568

  Painter, M J ^a   Syed, Q ^a   Tompkins, D ^a   O'Brien, Sarah J ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ENROFLOXACIN; ERYTHROMYCIN; FURAZOLIDONE; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NEOMYCIN; NORDIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYPRUS; FLUID INTAKE; FOOD INTAKE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PORTUGAL; RISK ASSESSMENT; RISK FACTOR; SPAIN; TRAVEL; UNITED KINGDOM;

ADULT; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CIPROFLOXACIN; CONFIDENCE INTERVALS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; RISK FACTORS; TRAVEL;

EID: 0036798670     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf173     Document Type: Article

References (31)

1. Public Health Laboratory Service. Campylobacter spp. Laboratory reports. England and Wales, faecal isolates, 1986-2000. [Online.] www.phls.co.uk/facts/gastro/campy/campyann.htm (16 March 2001, date last accessed).
2. Tam, C. (2001). Campylobacter reporting at its peak year of 1998: don't count your chickens yet. Communicable Disease and Public Health 4, 194-9.
3. Wheeler, J. G., Sethi, D., Cowden, J. M., Wall, P. G., Rodrigues, L. C., Tompkins, D. S. et al. (1999). Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. British Medical Journal 318, 1046-50.
4. Neal, K. R. & Slack, R. C. (1997). Diabetes mellitus, antisecretory drugs and other risk factors for campylobacter gastroenteritis in adults: a case-control study. Epidemiology and Infection 119, 307-11.
5. Skirrow, M. B. (1998). Infection with Campylobacter and Arcobacter. In Topley & Wilson's Microbiology and Microbial Infections-Bacterial Infections (Hausler, W. J., Jr & Sussman, M., Eds), pp. 567-80. Oxford University Press, New York, NY, USA.
6. Blaser, M. J. (2000). Campylobacter jejuni and related species. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 2276-85. Churchill Livingstone, Philadelphia, PA, USA.
7. Blaser, M. J. & Reller, L. B. (1981). Campylobacter enteritis. New England Journal of Medicine 305, 1444-52.
8. Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L., Tauxe, R. V. et al. (2001). Practice guidelines for the management of infectious diarrhea. Clinical Infectious Diseases 32, 331-51.
9. Food and Drug Administration Center for Veterinary Medicine. The human health impact of fluoroquinolone resistant campylobacter attributed to the consumption of chicken. [Online.] http://www.fda.gov/cvm/antimicrobial/Riskses.htm (5 January 2001, date last accessed).
10. Bowler, I. & Day, D. (1992). Emerging quinolone resistance in campylobacters. Lancet 340, 245.
11. Piddock, L. J. (1995). Quinolone resistance and Campylobacter spp. Journal of Antimicrobial Chemotherapy 36, 891-8.
12. Piddock, L. J. V. (1998). Fluoroquinolone resistance. British Medical Journal 317, 1029-30.
13. Endtz, H. P., Ruijs, G. J., van Klingeren, B., Jansen, W. H., van der Reyden, T. & Mouton, R. P. (1991). Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. Journal of Antimicrobial Chemotherapy 27, 199-208.
14. Jacobs-Reitsma, W. F., Kan, C. A. & Bolder, N. M. (1994). The induction of quinolone resistance in Campylobacter bacteria in broilers by quinolone treatment. Letters in Applied Microbiology 19, 228-31.
15. CDSC. (2000). Sentinel surveillance of campylobacter in England and Wales. Communicable Disease Report CDR Weekly 10, 169-72.
16. Bolton, F. J., Wareing, D. R., Skirrow, M. B. & Hutchinson, D. N. (1992). Identification and biotyping of campylobacters. In Identification Methods in Applied and Environmental Microbiology (Board, G. R., Jones, D. & Skinner, F. A, Eds), pp. 151-61. Blackwell Scientific Publications, Oxford, UK.
17. Frost, J. A., Oza, A. N., Thwaites, R. T. & Rowe, B. (1998). Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens. Journal of Clinical Microbiology 36, 335-9.
18. Frost, J. A., Kramer, J. M. & Gillanders, S. A. (1999). Phage typing of Campylobacter jejuni and Campylobacter coli and its use as an adjunct to serotyping. Epidemiology and Infection 123, 47-55.
19. Thwaites, R. T. & Frost, J. A. (1999). Drug resistance in Campylobacter jejuni, C. coli, and C. lari isolated from humans in north west England and Wales, 1997. Journal of Clinical Pathology 52, 812-4.
20. Office of Population Censuses and Surveys. (1991). Standard Occupational Classification Volume 3: Social Classification and Coding Methodology. HMSO, London, UK.
21. Gaunt, P. N. & Piddock, L. J. (1996). Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. Journal of Antimicrobial Chemotherapy 37, 747-57.
22. Smith, K. E., Besser, J. M., Hedberg, C. W., Leano, F. T., Bender, J. B., Wicklund, J. H. et al. (1999). Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. New England Journal of Medicine 340, 1525-32.
23. McCarthy, N. & Giesecke, J. (1999). Case-case comparisons to study causation of common infectious diseases. International Journal of Epidemiology 28, 764-8.
24. Velázques, J. B., Jiménez, A., Chomón, B. & Villa, T. G. (1995). Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 35, 173-8.
25. McDermott, P. F., Bodeis, S. M., English, L. L., White, D. G., Walker, R. D., Zhao, S., et al. (2002). Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. Journal of Infectious Diseases 185, 837-40.
26. Piddock, L. J. (1996). Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy? Journal of Antimicrobial Chemotherapy 38, 1-3.
27. Advisory Committee on the Microbiological Safety of Food. (1999). Report on Microbial Antibiotic Resistance in Relation to Food Safety. The Stationery Office, London, UK.
28. Department for Environment, Food & Rural Affairs. UK supplies and total for domestic usage of all carcase meat, bacon, ham and poultry meat. [Online.] www.defra.gov.uk/esg/excel/qtrmeat.xls (23 November 2001, date last updated; 17 January 2002, date last accessed).
29. Lea, G. & Leese, J. (2001). Prevention of travellers' diarrhoea and other food and water-borne diseases. In Health Information for Overseas Travel (Lea, G. & Leese, J., Eds), pp. 69-71. The Stationery Office, London, UK.
30. Piddock, L. J., Ricci, V., Stanley, K. & Jones, K. (2000). Activity of antibiotics used in human medicine for Campylobacter jejuni isolated from farm animals and their environment in Lancashire, UK. Journal of Antimicrobial Chemotherapy 46, 303-6.
31. Klatka, L. A., Hawkins, M. A., Pass, M. A., Angulo, F. J., Rohn, D. D., Morris, J. G. and the EIP FoodNet Working Group. (2002). Risk factors for sporadic Campylobacter infections in Maryland. International Conference on Emerging Infectious Disease, Atlanta, GA, USA. http://www.cdc.gov/foodnet/pub/iceid/2002/klatkahtm (Last accessed 16 August 2002).